In recent years, multi-state models have been studied widely in survival analysis. Despite their clear advantages, their use in biomedical and other applications has been rather limited so far. An important reason for this is the lack of flexible and user-friendly software for multi-state models. This paper introduces a package in R, called 'mstate', for each of the steps of the analysis of multi-state models. It can be applied to non- and semi-parametric models. The package contains functions to facilitate data preparation and flexible estimation of different types of covariate effects in the context of Cox regression models, functions to estimate patient-specific transition intensities, dynamic prediction probabilities and their associate...
Multi-state models can be used to describe processes in which an individual moves through a finite n...
When dealing with complex event history data in which individuals may experience more than one singl...
In longitudinal studies of disease, patients can experience several events across a follow-up perio...
In recent years, multi-state models have been studied widely in survival analysis. Despite their cle...
Multi-state models are a very useful tool to answer a wide range of questions in survival analysis t...
In longitudinal studies of disease, patients can experience several events across a followup period....
Multistate models are increasingly being used to model complex disease profiles. By modelling transi...
In longitudinal studies of disease, patients can experience several events across a followup period...
There is a clear growing interest, at least in the statistical literature, in competing risks and mu...
Multi-state models can be successfully used for describing complicated event history data, for examp...
Multi-state models (MSMs) are very useful for describing complicated event history data. These model...
One major goal in clinical applications of multi-state models is the estimation of transition probab...
In this paper the R package TP.idm to compute an empirical transition probability matrix for the ill...
aim Present different approaches for the estimation of transition probabilities in multi-state survi...
The multi-state Markov model is a useful way of describing a process in which an individual moves th...
Multi-state models can be used to describe processes in which an individual moves through a finite n...
When dealing with complex event history data in which individuals may experience more than one singl...
In longitudinal studies of disease, patients can experience several events across a follow-up perio...
In recent years, multi-state models have been studied widely in survival analysis. Despite their cle...
Multi-state models are a very useful tool to answer a wide range of questions in survival analysis t...
In longitudinal studies of disease, patients can experience several events across a followup period....
Multistate models are increasingly being used to model complex disease profiles. By modelling transi...
In longitudinal studies of disease, patients can experience several events across a followup period...
There is a clear growing interest, at least in the statistical literature, in competing risks and mu...
Multi-state models can be successfully used for describing complicated event history data, for examp...
Multi-state models (MSMs) are very useful for describing complicated event history data. These model...
One major goal in clinical applications of multi-state models is the estimation of transition probab...
In this paper the R package TP.idm to compute an empirical transition probability matrix for the ill...
aim Present different approaches for the estimation of transition probabilities in multi-state survi...
The multi-state Markov model is a useful way of describing a process in which an individual moves th...
Multi-state models can be used to describe processes in which an individual moves through a finite n...
When dealing with complex event history data in which individuals may experience more than one singl...
In longitudinal studies of disease, patients can experience several events across a follow-up perio...